1H-Indole-2-carboxylic acid, 5-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-, (2E)-2-(1H-indol-3-ylmethylene)hydrazide manufacturers
- CDK9-IN-18
-
- $1520.00
-
2026-07-27
- CAS:1804127-83-0
- Purity:
- Supply Ability: 10g
|
| | 1H-Indole-2-carboxylic acid, 5-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-, (2E)-2-(1H-indol-3-ylmethylene)hydrazide Basic information |
| | 1H-Indole-2-carboxylic acid, 5-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-, (2E)-2-(1H-indol-3-ylmethylene)hydrazide Chemical Properties |
| density | 1.42±0.1 g/cm3(Predicted) | | pka | 15.32±0.30(Predicted) |
| | 1H-Indole-2-carboxylic acid, 5-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-, (2E)-2-(1H-indol-3-ylmethylene)hydrazide Usage And Synthesis |
| Uses | CDK9-IN-18 is a potent CDK9 inhibitor. CDK9-IN-18 blocks the phosphorylation function of kinase CDK9. CDK9-IN-18 exhibits both good anticancer activity and low cellular activity. CDK9-IN-18 induces apoptosis. | | References | [1] Hu H, et al. Design, synthesis and biological evaluation of methylenehydrazine-1-carboxamide derivatives with (5-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)-1H-indole scaffold: Novel potential CDK9 inhibitors. Bioorg Chem. 2020 Sep;102:104064. DOI:10.1016/j.bioorg.2020.104064 |
| | 1H-Indole-2-carboxylic acid, 5-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-, (2E)-2-(1H-indol-3-ylmethylene)hydrazide Preparation Products And Raw materials |
|